Solution
Industries
Resources
About
Beacon Search

PROTEOGENIX

Company Snapshot

Founded: 2003
Entity Type: Private
Region: France
Headquarter: France
Key Geographics: North America, Europe
Corporate Address: 19 rue de la Haye 67300 Schiltigheim France Tel. +33-(0)3-90-20-54-70 www.proteogenix.science

Company Overview

ProteoGenix is a biotechnology company headquartered in Schiltigheim, France, with a focus on providing a comprehensive range of services and products in the field of life sciences, particularly in molecular biology, protein engineering, and antibody development. Founded in 2003, ProteoGenix has emerged as a trusted partner for academic and industrial researchers, pharmaceutical companies, and diagnostic laboratories worldwide.

ProteoGenix provides gene synthesis, cloning, and molecular biology services to support research and development projects. The company offers custom gene synthesis, vector construction, site-directed mutagenesis, and plasmid preparation services, enabling researchers to generate customized DNA constructs for gene expression, functional genomics, and synthetic biology applications.

PROTEOGENIX In Reports

Gene Synthesis: Technologies and Global Markets

BCC Research Market Analyst says global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028 at a CAGR of 15.8%.

Proteomics: Technologies and Global Markets

Global proteomics market should reach $55.1 billion by 2027 from $27.1 billion in 2022 at a CAGR of 15.3% for the forecast period of 2022 to 2027.

Protein Expression: Global Markets

The global market for protein expression should grow from $1.8 billion in 2017 to $3.1 billion by 2022 at a compound annual growth rate (CAGR) of 11.3% from 2017 through 2022. Detailed analysis of the production of...

View All Reports

PROTEOGENIX In News

ProteoGenix launches new XtenCHOTM Transient CHO Expression System to improve biologics development - News-Medical

News-Medical - Mar 30, 2022

Assessment of the $1.41 Billion Peptide Synthesis Industry - GlobeNewswire

GlobeNewswire - Mar 04, 2025

As a “symbol of peace,” 16-year-old injected parts of the Qur’an and Bible into himself as DNA - qz.com

qz.com - Feb 05, 2022

A French Teenager Turned the Bible and Quran into DNA and Injected Them into His Body - Live Science

Live Science - Dec 24, 2018

Company's Business Segments

  • Therapeutic Antibody Development Service : The company provides antibody services, therapeutic antibody services, protein services, gene services, peptide services, and bioreagents.

Applications/End User Industries

  • Biopharmaceutical
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2025 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI Sentiment